Allosteric muscarinic M1 receptor action of hybrids related to the M1 agonist xanomeline and to tacrine

被引：0
|
作者：
Jumpertz, S. [1 ]
Fang, L. [2 ]
Decker, M. [3 ]
Zhang, Y. [2 ]
Mohr, K. [1 ]
Traenkle, C. [1 ]
机构：
[1] Univ Bonn, Inst Pharm, D-5300 Bonn, Germany
[2] China Pharm Univ, Ctr Drug Discovery, Nanjing, Peoples R China
[3] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland
来源：
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY | 2009年 / 379卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
40
引用
收藏
页码：15 / 15
页数：1
相关论文
共 50 条
  • [1] Persistent receptor activation by the M1 muscarinic agonist, xanomeline
    El-Fakahany, EE
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    [J]. BIOLOGICAL PSYCHIATRY, 1998, 43 : 32S - 32S
  • [2] In Vivo Pharmacological Comparison of TAK-071, a Positive Allosteric Modulator of Muscarinic M1 Receptor, and Xanomeline, an Agonist of Muscarinic M1/M4 Receptor, in Rodents
    Mandai, Takao
    Kasahara, Maki
    Kurimoto, Emi
    Tanaka, Maiko
    Suzuki, Motohisa
    Nakatani, Atsushi
    Kimura, Haruhide
    [J]. NEUROSCIENCE, 2019, 414 : 60 - 76
  • [3] The M1 muscarinic acetylcholine receptor agonist xanomeline suppresses lethal inflammation
    Pavlov, Valentin A.
    Ochani, Mahendar
    Ochani, Kanta
    Rosas-Ballina, Mauricio
    Al-Abed, Yousef
    Tracey, Kevin J.
    [J]. FASEB JOURNAL, 2009, 23
  • [4] XANOMELINE - A POTENT AND SELECTIVE M1 MUSCARINIC AGONIST IN-VITRO
    MITCH, CH
    BYMASTER, FP
    CALLIGARO, DO
    QUIMBY, SJ
    SAWYER, BD
    SHANNON, HE
    WARD, JS
    OLESEN, PH
    SAUERBERG, P
    SHEARDOWN, MJ
    SUZDAK, PD
    [J]. NEUROBIOLOGY OF AGING, 1994, 15 : S104 - S104
  • [5] Hybrid Molecules from Xanomeline and Tacrine: Enhanced Tacrine Actions on Cholinesterases and Muscarinic M1 Receptors
    Fang, Lei
    Jumpertz, Sabine
    Zhang, Yihua
    Appenroth, Dorothea
    Fleck, Christian
    Mohr, Klaus
    Traenkle, Christian
    Decker, Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) : 2094 - 2103
  • [6] Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor
    Jakubík, J
    Tucek, S
    El-Fakahany, EE
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (03): : 1033 - 1041
  • [7] On the unique binding and activating properties of xanomeline at the M1 muscarinic acetylcholine receptor
    Christopoulos, A
    Pierce, TL
    Sorman, JL
    El-Fakahany, EE
    [J]. MOLECULAR PHARMACOLOGY, 1998, 53 (06) : 1120 - 1130
  • [8] Regulation of the M1 muscarinic acetylcholine receptor by orthosteric and allosteric ligands
    Thomas, R.
    Langmead, C.
    Wood, M.
    Challiss, J.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 28 - 28
  • [9] Identification of multiple allosteric sites on the M1 muscarinic acetylcholine receptor
    Espinoza-Fonseca, LM
    Trujillo-Ferrara, JG
    [J]. FEBS LETTERS, 2005, 579 (30) : 6726 - 6732
  • [10] Molecular Determinants of Allosteric Modulation at the M1 Muscarinic Acetylcholine Receptor
    Abdul-Ridha, Alaa
    Lopez, Laura
    Keov, Peter
    Thal, David M.
    Mistry, Shailesh N.
    Sexton, Patrick M.
    Lane, J. Robert
    Canals, Meritxell
    Christopoulos, Arthur
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2014, 289 (09) : 6067 - 6079
12345